<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?DTDIdentifier.IdentifierValue article.dtd?><?DTDIdentifier.IdentifierType system?><?SourceDTD.DTDName article.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName bmc2nlm.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Med Genet</journal-id><journal-title>BMC Medical Genetics</journal-title><issn pub-type="epub">1471-2350</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1471-2350-10-96</article-id><article-id pub-id-type="pmid">19772594</article-id><article-id pub-id-type="doi">10.1186/1471-2350-10-96</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Association analyses of the <italic>INSIG2 </italic>polymorphism in the obesity and cholesterol levels of Korean populations</article-title></title-group><contrib-group><contrib id="A1" contrib-type="author"><name><surname>Cha</surname><given-names>Seongwon</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>scha@kiom.re.kr</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Koo</surname><given-names>Imhoi</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>Imhoi.koo@kiom.re.kr</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Choi</surname><given-names>Sun Mi</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>smchoi@kiom.re.kr</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Park</surname><given-names>Byung Lae</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>blpark@snp-genetics.com</email></contrib><contrib id="A5" contrib-type="author"><name><surname>Kim</surname><given-names>Kil Soo</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>master@kirindiet.co.kr</email></contrib><contrib id="A6" contrib-type="author"><name><surname>Kim</surname><given-names>Jae-Ryong</given-names></name><xref ref-type="aff" rid="I4">4</xref><email>kimjr@med.yu.ac.kr</email></contrib><contrib id="A7" contrib-type="author"><name><surname>Shin</surname><given-names>Hyoung Doo</given-names></name><xref ref-type="aff" rid="I2">2</xref><xref ref-type="aff" rid="I5">5</xref><email>hdshin@sogang.ac.kr</email></contrib><contrib id="A8" corresp="yes" contrib-type="author"><name><surname>Kim</surname><given-names>Jong Yeol</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>ssmed@kiom.re.kr</email></contrib></contrib-group><aff id="I1"><label>1</label>Division of Constitutional Medicine Research, Korea Institute of Oriental Medicine, 483 Exporo, Yuseong-gu, Daejeon, 305-811, Republic of Korea</aff><aff id="I2"><label>2</label>Department of Genetic Epidemiology, SNP Genetics Inc., 14th Floor, Woolim-rall'ey B, Gasan-dong, Geumcheon-gu, Seoul, 153-803, Republic of Korea</aff><aff id="I3"><label>3</label>Obesity Clinic, Kirin Oriental Medical Hospital, 38-25 Jamwon-dong, Seocho-gu, Seoul, 137-905, Republic of Korea</aff><aff id="I4"><label>4</label>Department of Biochemistry and Molecular Biology, College of Medicine, Yeungnam University, 317-1 Daemyung-Dong, Daegu, 705-717, Republic of Korea</aff><aff id="I5"><label>5</label>Department of Life Science, Sogang University, 1 Shinsu-dong, Mapo-gu, Seoul, 121-742, Republic of Korea</aff><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>22</day><month>9</month><year>2009</year></pub-date><volume>10</volume><fpage>96</fpage><lpage>96</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2350/10/96"/><history><date date-type="received"><day>13</day><month>2</month><year>2009</year></date><date date-type="accepted"><day>22</day><month>9</month><year>2009</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2009 Cha et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2009</copyright-year><copyright-holder>Cha et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author> Cha Seongwon scha@kiom.re.kr </dc:author><dc:title> Association analyses of the INSIG2 polymorphism in the obesity and cholesterol levels of Korean populations </dc:title><dc:date>2009</dc:date><dcterms:bibliographicCitation>BMC Medical Genetics 10(1): 96-. (2009)</dcterms:bibliographicCitation><dc:identifier type="sici">1471-2350(2009)10:1&#x0003c;96&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1471-2350</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p>While <italic>INSIG2 </italic>has been reported to be associated with BMI in many populations, conflicting results have prevented consensus over its role. In analyses of mice and cell cultures the gene has been found to be involved in the regulation of cholesterol synthesis; however, no relationship has been found with cholesterol metabolism in human epidemiological research. Therefore, this study attempts to assess the effect of rs7566605 near <italic>INSIG2 </italic>on both obesity- and cholesterol-related traits in Koreans.</p></sec><sec sec-type="methods"><title>Methods</title><p>The rs7566605 polymorphism was genotyped with 2,364 Koreans, and associations with obesity- and cholesterol-related traits were analyzed statistically via an ANOVA or T-test.</p></sec><sec><title>Results</title><p>Replication of an association with BMI, WHR, fat mass, fat percent, and abdominal fat area failed, and the C allele of rs7566605 was not associated significantly with total cholesterol, HDL cholesterol, or triglyceride. However, it was found in a meta-analysis of a dominant model that the C allele of rs7566605 appeared to affect the level of the total cholesterol, especially in female subjects.</p></sec><sec><title>Conclusion</title><p>We failed to show associations of rs7566605 with cholesterol- and obesity-related phenotypes, although we newly suggest the possible involvement of <italic>INSIG2 </italic>with the plasma level of the total cholesterol in women.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p><italic>INSIG2 </italic>is considered to be a candidate gene with respect to involvement in the development of obesity. A common variant located 10 kb upstream of the gene, rs7566605, was found to be associated with BMI in a recent genome-wide association study [<xref ref-type="bibr" rid="B1">1</xref>]. This association has been suitably replicated in several white [<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B3">3</xref>], African-American [<xref ref-type="bibr" rid="B1">1</xref>], and Asian populations [<xref ref-type="bibr" rid="B4">4</xref>-<xref ref-type="bibr" rid="B6">6</xref>]. However, the SNP did not have a genetic effect on obesity according to other studies including white [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B7">7</xref>-<xref ref-type="bibr" rid="B14">14</xref>], Afro-Caribbean [<xref ref-type="bibr" rid="B12">12</xref>], and Asian populations [<xref ref-type="bibr" rid="B15">15</xref>-<xref ref-type="bibr" rid="B17">17</xref>]. Hence, the <italic>INSIG2 </italic>polymorphism may have an important effect in overweight populations under certain environmental circumstances, given several positive associations found in studies of overweight subjects [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B4">4</xref>].</p><p>INSIG2 has attracted the attention of researchers due to its role in cholesterol metabolism [<xref ref-type="bibr" rid="B18">18</xref>]. The protein is known to reside in the endoplasmic reticulum, where it binds to SCAP to inhibit it from convoying SREBPs to the Golgi apparatus [<xref ref-type="bibr" rid="B18">18</xref>]. Eventually, INSIG2 prevents SREBP from activating cholesterol synthesis because SREBP cannot be processed and activated by the Golgi enzymes. These actions of INSIG2 were also reported in subsequent research involving mice [<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B19">19</xref>]. However, they have not been confirmed in research with human populations [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B20">20</xref>], although the prevalence of hypercholesterolemia was shown to be reduced in CC homozygotes of rs7566605 in Japanese-American women [<xref ref-type="bibr" rid="B16">16</xref>]. Even in that study, the SNP was not found to be associated with the levels of total cholesterol, HDL cholesterol, or triacylglycerol.</p><p>In the present study, a replication analysis for the association of rs7566605 with BMI as well as other obesity-related measures was conducted using Korean populations, as controversial results have also been reported with Asian populations. The genetic effects of <italic>INSIG2 </italic>rs7566605 on the cholesterol metabolic traits were evaluated in efforts to discover a possible role in human cholesterol metabolism.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Subjects</title><p>The Korean study population consisted of 996 subjects recruited from an obesity clinic at the Kirin Oriental Medical Hospital (Seoul, Korea) and 737 subjects recruited from an obesity clinic at the Yeungnam University Medical Center (Daegu, Korea) [<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B22">22</xref>]. The 996 subjects from the Kirin obesity clinic were chosen from 1,302 individuals who came for help for weight control between 2001 and 2004. These subjects did not have chronic diseases, such as hypertension, coronary artery disease, stroke, diabetes, and hyperlipidemia. The 737 healthy unrelated subjects from Daegu, Korea were randomly recruited from an unselected population that came for a routine health check-up at Yeungnam University Hospital. These subjects were not representative of the Korean general population, as they had visited obesity clinics in order to address weight issues and/or as they had been the healthy selected subjects. In order to confirm this association, we recruited 631 subjects from 12 oriental medical hospitals in Korea (this population is hereafter named Multicenter) for 2 years since 2007, in which 266 patients with chronic diseases, like hypertension, hyperlipidemia, diabetes, and stroke were removed from a total of 897 individuals. All subjects provided written informed consent, and this study was approved by the Institutional Review Board of the Korea Institute of Oriental Medicine (for Kirin and Multicenter) and Yeungnam University. With the subjects from the Kirin Oriental Medical Hospital, additional anthropometric features (in this case the fat mass and fat percent) and abdominal fat mass areas were measured. Anthropometric features were measured via bio-impedance analysis using a commercial device (Inbody 2.0 Biospace, Korea). Abdominal fat areas were measured from computerized tomography cross-sectional images (Hispeed CT/e, GE, USA) as previously described [<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B24">24</xref>]. Blood samples from all study subjects were drawn in the morning after overnight fasting. They were checked for biochemical measures of glucose, total cholesterol, triglyceride, and HDL cholesterol. They were also used for DNA extraction. The characteristics of the recruited individuals are listed in Table <xref ref-type="table" rid="T1">1</xref>.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Clinical characteristics of the enrolled subjects from two obesity clinics and Multicenter hospitals</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left"><bold>Feature</bold></td><td align="center"><bold>n (female %)</bold></td><td align="center"><bold>All</bold></td><td align="center"><bold>Male</bold></td><td align="center"><bold>Female</bold></td></tr></thead><tbody><tr><td align="left"><bold>Kirin</bold></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">Age (y)</td><td align="center">996(93)</td><td align="center">27.9 &#x000b1; 8.43</td><td align="center">29.3 &#x000b1; 12.1</td><td align="center">27.8 &#x000b1; 8.07</td></tr><tr><td align="left">BMI (Kg/m<sup>2</sup>)</td><td align="center">996(93)</td><td align="center">26.4 &#x000b1; 4.70</td><td align="center">32.6 &#x000b1; 5.48</td><td align="center">25.9 &#x000b1; 4.27</td></tr><tr><td align="left">Total cholesterol (mmol/L)</td><td align="center">908(93)</td><td align="center">4.92 &#x000b1; 1.59</td><td align="center">4.69 &#x000b1; 1.41</td><td align="center">4.93 &#x000b1; 1.60</td></tr><tr><td align="left">HDL cholesterol (mmol/L)</td><td align="center">782(92)</td><td align="center">1.60 &#x000b1; 0.910</td><td align="center">1.63 &#x000b1; 1.29</td><td align="center">1.59 &#x000b1; 0.868</td></tr><tr><td align="left">Triglyceride (mmol/L)</td><td align="center">916(93)</td><td align="center">1.01 &#x000b1; 0.602</td><td align="center">1.66 &#x000b1; 1.09</td><td align="center">0.963 &#x000b1; 0.516</td></tr><tr><td align="left">Glucose (mmol/L)</td><td align="center">894(93)</td><td align="center">5.63 &#x000b1; 1.69</td><td align="center">6.57 &#x000b1; 2.81</td><td align="center">5.57 &#x000b1; 1.56</td></tr><tr><td align="left"><bold>Yeungnam</bold></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">Age (y)</td><td align="center">737(37)</td><td align="center">45.5 &#x000b1; 11.0</td><td align="center">43.3 &#x000b1; 10.6</td><td align="center">49.0 &#x000b1; 10.8</td></tr><tr><td align="left">BMI (Kg/m<sup>2</sup>)</td><td align="center">737(37)</td><td align="center">27.1 &#x000b1; 3.44</td><td align="center">27.4 &#x000b1; 30.6</td><td align="center">26.5 &#x000b1; 3.93</td></tr><tr><td align="left">Total cholesterol (mmol/L)</td><td align="center">737(37)</td><td align="center">5.36 &#x000b1; 0.960</td><td align="center">5.38 &#x000b1; 0.955</td><td align="center">5.32 &#x000b1; 0.968</td></tr><tr><td align="left">HDL cholesterol (mmol/L)</td><td align="center">737(37)</td><td align="center">1.37 &#x000b1; 0.346</td><td align="center">1.31 &#x000b1; 0.329</td><td align="center">1.48 &#x000b1; 0.345</td></tr><tr><td align="left">Triglyceride (mmol/L)</td><td align="center">737(37)</td><td align="center">1.81 &#x000b1; 1.39</td><td align="center">2.04 &#x000b1; 1.53</td><td align="center">1.41 &#x000b1; 1.01</td></tr><tr><td align="left">Glucose (mmol/L)</td><td align="center">736(37)</td><td align="center">5.38 &#x000b1; 1.36</td><td align="center">5.47 &#x000b1; 1.57</td><td align="center">5.21 &#x000b1; 0.903</td></tr><tr><td align="left"><bold>Multicenter</bold></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">Age (y)</td><td align="center">631(64)</td><td align="center">43.4 &#x000b1; 14.0</td><td align="center">44.0 &#x000b1; 13.6</td><td align="center">42.1 &#x000b1; 14.7</td></tr><tr><td align="left">BMI (Kg/m<sup>2</sup>)</td><td align="center">627(64)</td><td align="center">23.0 &#x000b1; 3.16</td><td align="center">22.7 &#x000b1; 3.24</td><td align="center">23.4 &#x000b1; 2.99</td></tr><tr><td align="left">Total cholesterol (mmol/L)</td><td align="center">600(64)</td><td align="center">4.82 &#x000b1; 0.809</td><td align="center">4.84 &#x000b1; 0.807</td><td align="center">4.78 &#x000b1; 0.815</td></tr><tr><td align="left">HDL cholesterol (mmol/L)</td><td align="center">601(64)</td><td align="center">0.882 &#x000b1; 0.0666</td><td align="center">0.883 &#x000b1; 0.0747</td><td align="center">0.881 &#x000b1; 0.0489</td></tr><tr><td align="left">Triglyceride (mmol/L)</td><td align="center">600(64)</td><td align="center">1.31 &#x000b1; 0.900</td><td align="center">1.13 &#x000b1; 0.677</td><td align="center">1.64 &#x000b1; 1.13</td></tr><tr><td align="left">Glucose (mmol/L)</td><td align="center">600(64)</td><td align="center">5.15 &#x000b1; 0.895</td><td align="center">5.10 &#x000b1; 0.803</td><td align="center">5.25 &#x000b1; 1.04</td></tr></tbody></table><table-wrap-foot><p>Mean &#x000b1; standard deviation values are given.</p></table-wrap-foot></table-wrap></sec><sec><title>Genotyping</title><p>The rs7566605 SNP of the <italic>INSIG2 </italic>gene was genotyped with TaqMan [<xref ref-type="bibr" rid="B25">25</xref>], according to the manufacturer's instructions (Applied Biosystems, Foster City, CA). The intensities of the fluorescence in the assay products were read with Prism 7900 HT instrument (Applied Biosystems). The genotyping failed in 8 individuals of the Kirin and Yeungnam populations, therefore they were removed in the subsequent analysis (the genotyping call rate was 99.5%.). The genotypes of the rs7566605 SNP in individuals from the Multicenter population were obtained by using the commercial Affymetrix GeneChip<sup>&#x000ae; </sup>Human Mapping 500K Array Set (Affymetrix Inc., CA, USA). The genotyping failed in 6 individuals, and they were also removed in the subsequent analysis (The genotyping call rate was 99.0%.).</p></sec><sec><title>Statistical analyses</title><p>&#x003c7;<sup>2 </sup>tests were used to determine whether the variant was in equilibrium at its locus in the population (Hardy-Weinberg equilibrium). The effects of the genetic polymorphism on obesity-related measures and cholesterol metabolic traits were assessed by an ANOVA for three genotypes or by a T-test for the dominant and recessive models. Meta-analysis was performed to combine statistical information from independent data sets. The results of the meta-analysis are considered more powerful estimates of the true effect size than those of each study. Bonferroni correction for multiple comparisons was also performed to remove any false positives. All statistical analyses were performed using SAS, version 8.02 (SAS, USA) and Matlab, Version 7.6 (MathWorks, Natick, MA).</p></sec></sec><sec><title>Results</title><sec><title>Association analyses with obesity-related measures</title><p>Replication analyses were performed for the association of SNP rs7566605 (located 10 kb upstream of the <italic>INSIG2 </italic>transcription start site) with BMI in three Korean populations (total <italic>n </italic>= 2,634). The allele of rs7566605 was in Hardy-Weinberg equilibrium in all three populations (<italic>P </italic>= 0.415 for Kirin; <italic>P </italic>= 0.911 for Yeungnam; <italic>P </italic>= 0.806 for Multicenter). The each MAF of the SNP in three populations was very similar to the frequency (0.37) for the white population [<xref ref-type="bibr" rid="B1">1</xref>] (0.35 for Kirin and Yeungnam populations and 0.33 for Multicenter population; 0.37 for white population).</p><p>Association of the rs7566605 genotype with BMI was not found in all three populations (Table <xref ref-type="table" rid="T2">2</xref>). When association analyses were extended to include other phenotypes in relation to the considered body features (in this case the WHR, fat mass, fat percent, total AFA, and subcutaneous and visceral AFA), no associations were found for Koreans (Table <xref ref-type="table" rid="T3">3</xref>). When the population was divided into two subgroups according to gender (male and female), no associations were shown in either subgroup (Table <xref ref-type="table" rid="T2">2</xref> and Table <xref ref-type="table" rid="T3">3</xref>). Associations with obesity-related traits were also not found after the meta-analysis with three populations (data not shown). Therefore, the association between rs7566605 and BMI (as well as other obesity-related measures) was not suitably replicated in Koreans.</p><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Association analyses of <italic>INSIG2 </italic>rs7566605 with BMI</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td></td><td></td><td align="center" colspan="3"><bold>n (mean &#x000b1; SD)</bold></td></tr><tr><td></td><td></td><td></td><td colspan="3"><hr></hr></td></tr><tr><td align="center"><bold>Population</bold></td><td align="center"><bold>Group</bold></td><td align="center"><bold>MAF</bold></td><td align="center"><bold>G/G</bold></td><td align="center"><bold>G/C</bold></td><td align="center"><bold>C/C</bold></td></tr></thead><tbody><tr><td align="center">Kirin</td><td align="center">Total</td><td align="center">0.35</td><td align="center">428(26.5 &#x000b1; 4.61)</td><td align="center">432(26.3 &#x000b1; 4.74)</td><td align="center">131(26.1 &#x000b1; 4.88)</td></tr><tr><td></td><td></td><td></td><td align="left" colspan="3"><italic>P</italic><sub><italic>ANOVA </italic></sub>= 0.689, <italic>P</italic><sub><italic>dom </italic></sub>= 0.423, <italic>P</italic><sub><italic>rec </italic></sub>= 0.564</td></tr><tr><td></td><td align="center">Female</td><td align="center">0.35</td><td align="center">400(26.1 &#x000b1; 4.41)</td><td align="center">400(25.7 &#x000b1; 3.96)</td><td align="center">120(25.8 &#x000b1; 4.82)</td></tr><tr><td></td><td></td><td></td><td align="left" colspan="3"><italic>P</italic><sub><italic>ANOVA </italic></sub>= 0.311, <italic>P</italic><sub><italic>dom </italic></sub>= 0.137, <italic>P</italic><sub><italic>rec </italic></sub>= 0.864</td></tr><tr><td></td><td align="center">Male</td><td align="center">0.38</td><td align="center">28(32.0 &#x000b1; 3.98)</td><td align="center">32(34.2 &#x000b1; 6.36)</td><td align="center">11(29.7 &#x000b1; 4.79)</td></tr><tr><td></td><td></td><td></td><td align="left" colspan="3"><italic>P</italic><sub><italic>ANOVA </italic></sub>= 0.040, <italic>P</italic><sub><italic>dom </italic></sub>= 0. 405, <italic>P</italic><sub><italic>rec </italic></sub>= 0.0525</td></tr><tr><td align="center">Yeungnam</td><td align="center">Total</td><td align="center">0.35</td><td align="center">312(27.0 &#x000b1; 3.35)</td><td align="center">329(27.2 &#x000b1; 3.57)</td><td align="center">93(27.0 &#x000b1; 3.26)</td></tr><tr><td></td><td></td><td></td><td align="left" colspan="3"><italic>P</italic><sub><italic>ANOVA </italic></sub>= 0.824, <italic>P</italic><sub><italic>dom </italic></sub>= 0.751, <italic>P</italic><sub><italic>rec </italic></sub>= 0.789</td></tr><tr><td></td><td align="center">Female</td><td align="center">0.34</td><td align="center">121(26.1 &#x000b1; 3.80)</td><td align="center">119(26.8 &#x000b1; 4.06)</td><td align="center">34(26.3 &#x000b1; 3.92)</td></tr><tr><td></td><td></td><td></td><td align="left" colspan="3"><italic>P</italic><sub><italic>ANOVA </italic></sub>= 0.378, <italic>P</italic><sub><italic>dom </italic></sub>= 0.218, <italic>P</italic><sub><italic>rec </italic></sub>= 0.837</td></tr><tr><td></td><td align="center">Male</td><td align="center">0.36</td><td align="center">191(27.5 &#x000b1; 2.93)</td><td align="center">210(27.3 &#x000b1; 3.26)</td><td align="center">59(27.3 &#x000b1; 2.78)</td></tr><tr><td></td><td></td><td></td><td align="left" colspan="3"><italic>P</italic><sub><italic>ANOVA </italic></sub>= 0.765, <italic>P</italic><sub><italic>dom </italic></sub>= 0.464, <italic>P</italic><sub><italic>rec </italic></sub>= 0.835</td></tr><tr><td align="center">Multicenter</td><td align="center">Total</td><td align="center">0.33</td><td align="center">272(23.1 &#x000b1; 3.31)</td><td align="center">287(22.7 &#x000b1; 2.99)</td><td align="center">66(23.5 &#x000b1; 3.24)</td></tr><tr><td></td><td></td><td></td><td align="left" colspan="3"><italic>P</italic><sub><italic>ANOVA </italic></sub>= 0.161, <italic>P</italic><sub><italic>dom </italic></sub>= 0.461, <italic>P</italic><sub><italic>rec </italic></sub>= 0.145</td></tr><tr><td></td><td align="center">Female</td><td align="center">0.35</td><td align="center">168(22.9 &#x000b1; 3.41)</td><td align="center">183(22.3 &#x000b1; 3.03)</td><td align="center">47(23.4 &#x000b1; 3.29)</td></tr><tr><td></td><td></td><td></td><td align="left" colspan="3"><italic>P</italic><sub><italic>ANOVA </italic></sub>= 0.066, <italic>P</italic><sub><italic>dom </italic></sub>= 0.234, <italic>P</italic><sub><italic>rec </italic></sub>= 0.127</td></tr><tr><td></td><td align="center">Male</td><td align="center">0.31</td><td align="center">104(23.2 &#x000b1; 3.15)</td><td align="center">104(23.4 &#x000b1; 2.81)</td><td align="center">19(23.7 &#x000b1; 3.18)</td></tr><tr><td></td><td></td><td></td><td align="left" colspan="3"><italic>P</italic><sub><italic>ANOVA </italic></sub>= 0.790, <italic>P</italic><sub><italic>dom </italic></sub>= 0.581, <italic>P</italic><sub><italic>rec </italic></sub>= 0.585</td></tr></tbody></table><table-wrap-foot><p>The <italic>P </italic>values for BMI in subjects with minor alleles were assessed by an ANOVA for a difference among three genotypes or by a T-test for the dominant and recessive models. The significant threshold was 0.0015 for the Kirin population (11 phenotypes and 3 different models) and 0.0033 for the Yeungnam and Multicenter populations (5 phenotypes and 3 different models).</p></table-wrap-foot></table-wrap><table-wrap position="float" id="T3"><label>Table 3</label><caption><p>Association analysis of <italic>INSIG2 </italic>rs7566605 with the body features of the Kirin population</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td></td><td></td><td align="center" colspan="3"><bold>n (mean &#x000b1; SD)</bold></td></tr><tr><td></td><td></td><td></td><td colspan="3"><hr></hr></td></tr><tr><td align="center"><bold>Group</bold></td><td align="center"><bold>Phenotype</bold></td><td align="center"><bold>MAF</bold></td><td align="center"><bold>G/G</bold></td><td align="center"><bold>G/C</bold></td><td align="center"><bold>C/C</bold></td></tr></thead><tbody><tr><td align="center">Total</td><td align="center">WHR</td><td align="center">0.35</td><td align="center">428(0.888 &#x000b1; 0.0728)</td><td align="center">432(0.885 &#x000b1; 0.0776)</td><td align="center">131(0.887 &#x000b1; 0.0811)</td></tr><tr><td></td><td></td><td></td><td align="left" colspan="3"><italic>P</italic><sub><italic>ANOVA </italic></sub>= 0.825, <italic>P</italic><sub><italic>dom </italic></sub>= 0.554, <italic>P</italic><sub><italic>rec </italic></sub>= 0.977</td></tr><tr><td></td><td align="center">Fat mass</td><td align="center">0.35</td><td align="center">428(24.4 &#x000b1; 8.36)</td><td align="center">432(23.8 &#x000b1; 8.77)</td><td align="center">131(23.8 &#x000b1; 8.67)</td></tr><tr><td></td><td></td><td></td><td align="left" colspan="3"><italic>P</italic><sub><italic>ANOVA </italic></sub>= 0.590, <italic>P</italic><sub><italic>dom </italic></sub>= 0.305, <italic>P</italic><sub><italic>rec </italic></sub>= 0.689</td></tr><tr><td></td><td align="center">Fat percent</td><td align="center">0.35</td><td align="center">428(34.3 &#x000b1; 5.86)</td><td align="center">432(33.9 &#x000b1; 6.13)</td><td align="center">131(34.2 &#x000b1; 6.58)</td></tr><tr><td></td><td></td><td></td><td align="left" colspan="3"><italic>P</italic><sub><italic>ANOVA </italic></sub>= 0.526, <italic>P</italic><sub><italic>dom </italic></sub>= 0.318, <italic>P</italic><sub><italic>rec </italic></sub>= 0.869</td></tr><tr><td></td><td align="center">Total AFA</td><td align="center">0.35</td><td align="center">422(293 &#x000b1; 123)</td><td align="center">430(291 &#x000b1; 131)</td><td align="center">130(280 &#x000b1; 122)</td></tr><tr><td></td><td></td><td></td><td align="left" colspan="3"><italic>P</italic><sub><italic>ANOVA </italic></sub>= 0.618, <italic>P</italic><sub><italic>dom </italic></sub>= 0.571, <italic>P</italic><sub><italic>rec </italic></sub>= 0.344</td></tr><tr><td></td><td align="center">Visceral AFA</td><td align="center">0.35</td><td align="center">422(65.7 &#x000b1; 43.4)</td><td align="center">430(65.5 &#x000b1; 47.1)</td><td align="center">130(60.2 &#x000b1; 40.3)</td></tr><tr><td></td><td></td><td></td><td align="left" colspan="3"><italic>P</italic><sub><italic>ANOVA </italic></sub>= 0.439, <italic>P</italic><sub><italic>dom </italic></sub>= 0.626, <italic>P</italic><sub><italic>rec </italic></sub>= 0.164</td></tr><tr><td></td><td align="center">Subcutaneous AFA</td><td align="center">0.35</td><td align="center">422(228 &#x000b1; 98.0)</td><td align="center">430(225 &#x000b1; 103)</td><td align="center">130(220 &#x000b1; 101)</td></tr><tr><td></td><td></td><td></td><td align="left" colspan="3"><italic>P</italic><sub><italic>ANOVA </italic></sub>= 0.758, <italic>P</italic><sub><italic>dom </italic></sub>= 0.569, <italic>P</italic><sub><italic>rec </italic></sub>= 0.519</td></tr><tr><td align="center">Female</td><td align="center">WHR</td><td align="center">0.35</td><td align="center">400(0.882 &#x000b1; 0.0697)</td><td align="center">400(0.875 &#x000b1; 0.0664)</td><td align="center">120(0.881 &#x000b1; 0.0798)</td></tr><tr><td></td><td></td><td></td><td align="left" colspan="3"><italic>P</italic><sub><italic>ANOVA </italic></sub>= 0.293, <italic>P</italic><sub><italic>dom </italic></sub>= 0.175, <italic>P</italic><sub><italic>rec </italic></sub>= 0.782</td></tr><tr><td></td><td align="center">Fat mass</td><td align="center">0.35</td><td align="center">400(23.9 &#x000b1; 8.17)</td><td align="center">400(22.9 &#x000b1; 7.65)</td><td align="center">120(23.6 &#x000b1; 8.64)</td></tr><tr><td></td><td></td><td></td><td align="left" colspan="3"><italic>P</italic><sub><italic>ANOVA </italic></sub>= 0.228, <italic>P</italic><sub><italic>dom </italic></sub>= 0.123, <italic>P</italic><sub><italic>rec </italic></sub>= 0.845</td></tr><tr><td></td><td align="center">Fat percent</td><td align="center">0.35</td><td align="center">400(34.5 &#x000b1; 5.89)</td><td align="center">400(33.9 &#x000b1; 6.14)</td><td align="center">120(34.5 &#x000b1; 6.62)</td></tr><tr><td></td><td></td><td></td><td align="left" colspan="3"><italic>P</italic><sub><italic>ANOVA </italic></sub>= 0.332, <italic>P</italic><sub><italic>dom </italic></sub>= 0.261, <italic>P</italic><sub><italic>rec </italic></sub>= 0.576</td></tr><tr><td></td><td align="center">Total AFA</td><td align="center">0.35</td><td align="center">394(285 &#x000b1; 119)</td><td align="center">398(276 &#x000b1; 118)</td><td align="center">119(277 &#x000b1; 121)</td></tr><tr><td></td><td></td><td></td><td align="left" colspan="3"><italic>P</italic><sub><italic>ANOVA </italic></sub>= 0.544, <italic>P</italic><sub><italic>dom </italic></sub>= 0.270, <italic>P</italic><sub><italic>rec </italic></sub>= 0.742</td></tr><tr><td></td><td align="center">Visceral AFA</td><td align="center">0.35</td><td align="center">394(607 &#x000b1; 369)</td><td align="center">398(591 &#x000b1; 37.8)</td><td align="center">119(556 &#x000b1; 32.9)</td></tr><tr><td></td><td></td><td></td><td align="left" colspan="3"><italic>P</italic><sub><italic>ANOVA </italic></sub>= 0.399, <italic>P</italic><sub><italic>dom </italic></sub>= 0.313, <italic>P</italic><sub><italic>rec </italic></sub>= 0.192</td></tr><tr><td></td><td align="center">Subcutaneous AFA</td><td align="center">0.35</td><td align="center">394(225 &#x000b1; 97.0)</td><td align="center">398(217 &#x000b1; 95.0)</td><td align="center">119(221 &#x000b1; 102)</td></tr><tr><td></td><td></td><td></td><td align="left" colspan="3"><italic>P</italic><sub><italic>ANOVA </italic></sub>= 0.533, <italic>P</italic><sub><italic>dom </italic></sub>= 0.295, <italic>P</italic><sub><italic>rec </italic></sub>= 0.982</td></tr><tr><td align="center">Male</td><td align="center">WHR</td><td align="center">0.38</td><td align="center">28(0.976 &#x000b1; 0.0598)</td><td align="center">32(1.02 &#x000b1; 0.0891)</td><td align="center">11(0.954 &#x000b1; 0.0656)</td></tr><tr><td></td><td></td><td></td><td align="left" colspan="3"><italic>P</italic><sub><italic>ANOVA </italic></sub>= 0.0292, <italic>P</italic><sub><italic>dom </italic></sub>= 0.192, <italic>P</italic><sub><italic>rec </italic></sub>= 0.0923</td></tr><tr><td></td><td align="center">Fat mass</td><td align="center">0.38</td><td align="center">28(31.2 &#x000b1; 8.18)</td><td align="center">32(35.0 &#x000b1; 13.4)</td><td align="center">11(26.1 &#x000b1; 9.06)</td></tr><tr><td></td><td></td><td></td><td align="left" colspan="3"><italic>P</italic><sub><italic>ANOVA </italic></sub>= 0.0629, <italic>P</italic><sub><italic>dom </italic></sub>= 0.589, <italic>P</italic><sub><italic>rec </italic></sub>= 0.0510</td></tr><tr><td></td><td align="center">Fat percent</td><td align="center">0.38</td><td align="center">28(32.4 &#x000b1; 5.12)</td><td align="center">32(33.9 &#x000b1; 6.19)</td><td align="center">11(30.9 &#x000b1; 5.23)</td></tr><tr><td></td><td></td><td></td><td align="left" colspan="3"><italic>P</italic><sub><italic>ANOVA </italic></sub>= 0.730, <italic>P</italic><sub><italic>dom </italic></sub>= 0.607, <italic>P</italic><sub><italic>rec </italic></sub>= 0.207</td></tr><tr><td></td><td align="center">Total AFA</td><td align="center">0.38</td><td align="center">28(406 &#x000b1; 128)</td><td align="center">32(473 &#x000b1; 146)</td><td align="center">11(323 &#x000b1; 136)</td></tr><tr><td></td><td></td><td></td><td align="left" colspan="3"><italic>P</italic><sub><italic>ANOVA </italic></sub>= 0.00778, <italic>P</italic><sub><italic>dom </italic></sub>= 0.422, <italic>P</italic><sub><italic>rec </italic></sub>= 0.0120</td></tr><tr><td></td><td align="center">Visceral AFA</td><td align="center">0.38</td><td align="center">28(135 &#x000b1; 645)</td><td align="center">32(146 &#x000b1; 726)</td><td align="center">11(110 &#x000b1; 72.0)</td></tr><tr><td></td><td></td><td></td><td align="left" colspan="3"><italic>P</italic><sub><italic>ANOVA </italic></sub>= 0.345, <italic>P</italic><sub><italic>dom </italic></sub>= 0.928, <italic>P</italic><sub><italic>rec </italic></sub>= 0.213</td></tr><tr><td></td><td align="center">Subcutaneous AFA</td><td align="center">0.38</td><td align="center">28(271 &#x000b1; 103)</td><td align="center">32(327 &#x000b1; 139)</td><td align="center">11(213 &#x000b1; 94.3)</td></tr><tr><td></td><td></td><td></td><td align="left" colspan="3"><italic>P</italic><sub><italic>ANOVA </italic></sub>= 0.0199, <italic>P</italic><sub><italic>dom </italic></sub>= 0.347, <italic>P</italic><sub><italic>rec </italic></sub>= 0.0311</td></tr></tbody></table><table-wrap-foot><p>The <italic>P </italic>values for the AFA in subjects with minor alleles were assessed by an ANOVA for three genotypes or by a T-test for the dominant and recessive models. The significant threshold was 0.0015 for the Kirin population (11 phenotypes and 3 different models).</p></table-wrap-foot></table-wrap></sec><sec><title>Association analyses with cholesterol-related phenotypes and glucose</title><p>An association analysis with the plasma levels of glucose and cholesterol-related phenotypes (i.e., total cholesterol, HDL cholesterol, and triglyceride) was performed. No genetic effects of the SNP were detected with the levels of glucose, HDL cholesterol, and triglyceride. Among the three populations, the rs7566605 C allele only appeared to be associated with an increased level of total cholesterol in a dominant genetic model in the Kirin population (Table <xref ref-type="table" rid="T4">4</xref>). When the association was analyzed for subgroups divided by gender, the genetic effects of the rs7566605 seemed to be maintained in female subjects (Table <xref ref-type="table" rid="T4">4</xref>). When the meta-analysis was performed on the three populations (Kirin, Yeungnam, and Multicenter), the rs7566605 C allele was associated in the female subjects with an increased level of total cholesterol (Figure <xref ref-type="fig" rid="F1">1</xref>). After performing a correction for multiple comparisons with the Bonferroni correction, a significant effect could not be found on the plasma levels of the total cholesterol in female subgroups. However, a marginal association was detected in the total cholesterol levels.</p><fig position="float" id="F1"><label>Figure 1</label><caption><p><bold>The pooled effect sizes with 95% CIs for a total cholesterol level in female subgroup</bold>. When the meta-analysis was performed on the three populations, it was found that the rs7566605 SNP was associated with the total cholesterol level in a dominant model, especially in the female subgroup. After performing a Bonferroni correction, a significant effect could not be found on the plasma levels of the total cholesterol (significant threshold: P &#x0003c; 0.0033).</p></caption><graphic xlink:href="1471-2350-10-96-1"/></fig><table-wrap position="float" id="T4"><label>Table 4</label><caption><p>Association analysis of <italic>INSIG2 </italic>rs7566605 with the levels of cholesterol and triglyceride</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td></td><td></td><td align="center" colspan="3"><bold>n (mean &#x000b1; SD)</bold></td></tr><tr><td></td><td></td><td></td><td colspan="3"><hr></hr></td></tr><tr><td align="center"><bold>Group</bold></td><td align="center"><bold>Phenotype</bold></td><td align="center"><bold>MAF</bold></td><td align="center"><bold>G/G</bold></td><td align="center"><bold>G/C</bold></td><td align="center"><bold>C/C</bold></td></tr></thead><tbody><tr><td align="center" colspan="6"><bold>Kirin</bold></td></tr><tr><td align="center">Total</td><td align="center">Total cholesterol</td><td align="center">0.35</td><td align="center">389(4.76 &#x000b1; 1.42)</td><td align="center">395(5.12 &#x000b1; 1.77)</td><td align="center">122(4.76 &#x000b1; 1.36)</td></tr><tr><td></td><td></td><td></td><td align="left" colspan="3"><italic>P</italic><sub><italic>ANOVA </italic></sub>= 0.00250, <italic>P</italic><sub><italic>dom </italic></sub>= 0.0134, <italic>P</italic><sub><italic>rec </italic></sub>= 0.155</td></tr><tr><td></td><td align="center">HDL cholesterol</td><td align="center">0.35</td><td align="center">341(1.61 &#x000b1; 0.907)</td><td align="center">328(1.64 &#x000b1; 0.970)</td><td align="center">111(1.42 &#x000b1; 0.701)</td></tr><tr><td></td><td></td><td></td><td align="left" colspan="3"><italic>P</italic><sub><italic>ANOVA </italic></sub>= 0.0969, <italic>P</italic><sub><italic>dom </italic></sub>= 0.764, <italic>P</italic><sub><italic>rec </italic></sub>= 0.0352</td></tr><tr><td></td><td align="center">Triglyceride</td><td align="center">0.35</td><td align="center">394(1.03 &#x000b1; 0.567)</td><td align="center">398(0.968 &#x000b1; 0.597)</td><td align="center">122(1.09 &#x000b1; 0.708)</td></tr><tr><td></td><td></td><td></td><td align="left" colspan="3"><italic>P</italic><sub><italic>ANOVA </italic></sub>= 0.0415, <italic>P</italic><sub><italic>dom </italic></sub>= 0.117, <italic>P</italic><sub><italic>rec </italic></sub>= 0.186</td></tr><tr><td align="center">Female</td><td align="center">Total cholesterol</td><td align="center">0.35</td><td align="center">362(4.78 &#x000b1; 1.44)</td><td align="center">367(5.14 &#x000b1; 1.78)</td><td align="center">111(4.74 &#x000b1; 1.34)</td></tr><tr><td></td><td></td><td></td><td align="left" colspan="3"><italic>P</italic><sub><italic>ANOVA </italic></sub>= 0.00410, <italic>P</italic><sub><italic>dom </italic></sub>= 0.0170, <italic>P</italic><sub><italic>rec </italic></sub>= 0.178</td></tr><tr><td></td><td align="center">HDL cholesterol</td><td align="center">0.35</td><td align="center">314(1.64 &#x000b1; 0.904)</td><td align="center">300(1.61 &#x000b1; 0.896)</td><td align="center">100(1.41 &#x000b1; 0.618)</td></tr><tr><td></td><td></td><td></td><td align="left" colspan="3"><italic>P</italic><sub><italic>ANOVA </italic></sub>= 0.0647, <italic>P</italic><sub><italic>dom </italic></sub>= 0.265, <italic>P</italic><sub><italic>rec </italic></sub>= 0.0203</td></tr><tr><td></td><td align="center">Triglyceride</td><td align="center">0.35</td><td align="center">368(0.996 &#x000b1; 0.537)</td><td align="center">370(0.910 &#x000b1; 0.455)</td><td align="center">111(1.02 &#x000b1; 0.613)</td></tr><tr><td></td><td></td><td></td><td align="left" colspan="3"><italic>P</italic><sub><italic>ANOVA </italic></sub>= 0.0396, <italic>P</italic><sub><italic>dom </italic></sub>= 0.0877, <italic>P</italic><sub><italic>rec </italic></sub>= 0.235</td></tr><tr><td align="center">Male</td><td align="center">Total cholesterol</td><td align="center">0.38</td><td align="center">27(4.54 &#x000b1; 1.10)</td><td align="center">28(4.89 &#x000b1; 1.65)</td><td align="center">11(4.56 &#x000b1; 1.47)</td></tr><tr><td></td><td></td><td></td><td align="left" colspan="3"><italic>P</italic><sub><italic>ANOVA </italic></sub>= 0.629, <italic>P</italic><sub><italic>dom </italic></sub>= 0.480, <italic>P</italic><sub><italic>rec </italic></sub>= 0.728</td></tr><tr><td></td><td align="center">HDL cholesterol</td><td align="center">0.39</td><td align="center">27(1.30 &#x000b1; 0.891)</td><td align="center">28(1.95 &#x000b1; 1.54)</td><td align="center">11(1.62 &#x000b1; 1.30)</td></tr><tr><td></td><td></td><td></td><td align="left" colspan="3"><italic>P</italic><sub><italic>ANOVA </italic></sub>= 0.168, <italic>P</italic><sub><italic>dom </italic></sub>= 0.0804, <italic>P</italic><sub><italic>rec </italic></sub>= 0.984</td></tr><tr><td></td><td align="center">Triglyceride</td><td align="center">0.38</td><td align="center">26(1.57 &#x000b1; 0.708)</td><td align="center">28(1.73 &#x000b1; 1.33)</td><td align="center">11(1.67 &#x000b1; 1.26)</td></tr><tr><td></td><td></td><td></td><td align="left" colspan="3"><italic>P</italic><sub><italic>ANOVA </italic></sub>= 0.892, <italic>P</italic><sub><italic>dom </italic></sub>= 0.716, <italic>P</italic><sub><italic>rec </italic></sub>= 0.875</td></tr><tr><td align="center" colspan="6"><bold>Yeungnam</bold></td></tr><tr><td align="center">Total</td><td align="center">Total cholesterol</td><td align="center">0.35</td><td align="center">312 (5.35 &#x000b1; 0.913)</td><td align="center">329 (5.37 &#x000b1; 0.986)</td><td align="center">93(5.39 &#x000b1; 1.03)</td></tr><tr><td></td><td></td><td></td><td align="left" colspan="3"><italic>P</italic><sub><italic>ANOVA </italic></sub>= 0.930, <italic>P</italic><sub><italic>dom </italic></sub>= 0.751, <italic>P</italic><sub><italic>rec </italic></sub>= 0.760</td></tr><tr><td></td><td align="center">HDL cholesterol</td><td align="center">0.35</td><td align="center">312 (1.36 &#x000b1; 0.336)</td><td align="center">329 (1.38 &#x000b1; 0.360)</td><td align="center">93(1.37 &#x000b1; 0.333)</td></tr><tr><td></td><td></td><td></td><td align="left" colspan="3"><italic>P</italic><sub><italic>ANOVA </italic></sub>= 0.771, <italic>P</italic><sub><italic>dom </italic></sub>= 0.509, <italic>P</italic><sub><italic>rec </italic></sub>= 0.954</td></tr><tr><td></td><td align="center">Triglyceride</td><td align="center">0.35</td><td align="center">312 (1.83 &#x000b1; 1.33)</td><td align="center">329 (1.81 &#x000b1; 1.54)</td><td align="center">93(1.75 &#x000b1; 0.996)</td></tr><tr><td></td><td></td><td></td><td align="left" colspan="3"><italic>P</italic><sub><italic>ANOVA </italic></sub>= 0.802, <italic>P</italic><sub><italic>dom </italic></sub>= 0.675, <italic>P</italic><sub><italic>rec </italic></sub>= 0.726</td></tr><tr><td align="center">Female</td><td align="center">Total cholesterol</td><td align="center">0.34</td><td align="center">121(5.22 &#x000b1; 0.855)</td><td align="center">119(5.39 &#x000b1; 1.04)</td><td align="center">34(5.44 &#x000b1; 1.09)</td></tr><tr><td></td><td></td><td></td><td align="left" colspan="3"><italic>P</italic><sub><italic>ANOVA </italic></sub>= 0.296, <italic>P</italic><sub><italic>dom </italic></sub>= 0.124, <italic>P</italic><sub><italic>rec </italic></sub>= 0.445</td></tr><tr><td></td><td align="center">HDL cholesterol</td><td align="center">0.34</td><td align="center">121(1.49 &#x000b1; 0.343)</td><td align="center">119(1.47 &#x000b1; 0.357)</td><td align="center">34(1.51 &#x000b1; 0.323)</td></tr><tr><td></td><td></td><td></td><td align="left" colspan="3"><italic>P</italic><sub><italic>ANOVA </italic></sub>= 0.813, <italic>P</italic><sub><italic>dom </italic></sub>= 0.755, <italic>P</italic><sub><italic>rec </italic></sub>= 0.670</td></tr><tr><td></td><td align="center">Triglyceride</td><td align="center">0.34</td><td align="center">121(1.46 &#x000b1; 1.20)</td><td align="center">119(1.37 &#x000b1; 0.883)</td><td align="center">34(1.38 &#x000b1; 0.609)</td></tr><tr><td></td><td></td><td></td><td align="left" colspan="3"><italic>P</italic><sub><italic>ANOVA </italic></sub>= 0.784, <italic>P</italic><sub><italic>dom </italic></sub>= 0.610, <italic>P</italic><sub><italic>rec </italic></sub>= 0.781</td></tr><tr><td align="center">Male</td><td align="center">Total cholesterol</td><td align="center">0.36</td><td align="center">191 (5.43 &#x000b1; 0.943)</td><td align="center">210 (5.35 &#x000b1; 0.956)</td><td align="center">59 (5.36 &#x000b1; 1.01)</td></tr><tr><td></td><td></td><td></td><td align="left" colspan="3"><italic>P</italic><sub><italic>ANOVA </italic></sub>= 0.703, <italic>P</italic><sub><italic>dom </italic></sub>= 0.402, <italic>P</italic><sub><italic>rec </italic></sub>= 0.833</td></tr><tr><td></td><td align="center">HDL cholesterol</td><td align="center">0.36</td><td align="center">191 (1.28 &#x000b1; 0.307)</td><td align="center">210 (1.33 &#x000b1; 0.353)</td><td align="center">59 (1.29 &#x000b1; 0.316)</td></tr><tr><td></td><td></td><td></td><td align="left" colspan="3"><italic>P</italic><sub><italic>ANOVA </italic></sub>= 0.275, <italic>P</italic><sub><italic>dom </italic></sub>= 0.173, <italic>P</italic><sub><italic>rec </italic></sub>= 0.716</td></tr><tr><td></td><td align="center">Triglyceride</td><td align="center">0.36</td><td align="center">191 (2.06 &#x000b1; 1.36)</td><td align="center">210 (2.06 &#x000b1; 1.77)</td><td align="center">59 (1.96 &#x000b1; 1.11)</td></tr><tr><td></td><td></td><td></td><td align="left" colspan="3"><italic>P</italic><sub><italic>ANOVA </italic></sub>= 0.857, <italic>P</italic><sub><italic>dom </italic></sub>= 0.664, <italic>P</italic><sub><italic>rec </italic></sub>= 0.850</td></tr><tr><td align="center" colspan="6"><bold>Multicenter</bold></td></tr><tr><td align="center">Total</td><td align="center">Total cholesterol</td><td align="center">0.34</td><td align="center">258(4.80 &#x000b1; 0.818)</td><td align="center">277(4.80 &#x000b1; 0.804)</td><td align="center">63(4.97 &#x000b1; 0.798)</td></tr><tr><td></td><td></td><td></td><td align="left" colspan="3"><italic>P</italic><sub><italic>ANOVA </italic></sub>= 0.273, <italic>P</italic><sub><italic>dom </italic></sub>= 0.660, <italic>P</italic><sub><italic>rec </italic></sub>= 0.107</td></tr><tr><td></td><td align="center">HDL cholesterol</td><td align="center">0.34</td><td align="center">258(0.884 &#x000b1; 0.818)</td><td align="center">277(1.15 &#x000b1; 0.293)</td><td align="center">64(1.19 &#x000b1; 0.325)</td></tr><tr><td></td><td></td><td></td><td align="left" colspan="3"><italic>P</italic><sub><italic>ANOVA </italic></sub>= 0.870, <italic>P</italic><sub><italic>dom </italic></sub>= 0.625, <italic>P</italic><sub><italic>rec </italic></sub>= 0.965</td></tr><tr><td></td><td align="center">Triglyceride</td><td align="center">0.34</td><td align="center">258(1.31 &#x000b1; 0.949)</td><td align="center">277(1.35 &#x000b1; 0.904)</td><td align="center">63(1.15 &#x000b1; 0.639)</td></tr><tr><td></td><td></td><td></td><td align="left" colspan="3"><italic>P</italic><sub><italic>ANOVA </italic></sub>= 0.288, <italic>P</italic><sub><italic>dom </italic></sub>= 0.988, <italic>P</italic><sub><italic>rec </italic></sub>= 0.133</td></tr><tr><td align="center">Female</td><td align="center">Total cholesterol</td><td align="center">0.35</td><td align="center">159(4.81 &#x000b1; 0.798)</td><td align="center">179(4.81 &#x000b1; 0.819)</td><td align="center">46(5.03 &#x000b1; 0.780)</td></tr><tr><td></td><td></td><td></td><td align="left" colspan="3"><italic>P</italic><sub><italic>ANOVA </italic></sub>= 0.216, <italic>P</italic><sub><italic>dom </italic></sub>= 0.560, <italic>P</italic><sub><italic>rec </italic></sub>= 0.0801</td></tr><tr><td></td><td align="center">HDL cholesterol</td><td align="center">0.35</td><td align="center">159(0.883 &#x000b1; 0.0539)</td><td align="center">179(0.883 &#x000b1; 0.0972)</td><td align="center">47(0.879 &#x000b1; 0.0161)</td></tr><tr><td></td><td></td><td></td><td align="left" colspan="3"><italic>P</italic><sub><italic>ANOVA </italic></sub>= 0.943, <italic>P</italic><sub><italic>dom </italic></sub>= 0.894, <italic>P</italic><sub><italic>rec </italic></sub>= 0.733</td></tr><tr><td></td><td align="center">Triglyceride</td><td align="center">0.35</td><td align="center">159(1.18 &#x000b1; 0.764)</td><td align="center">179(1.12 &#x000b1; 0.646)</td><td align="center">46(0.99 &#x000b1; 0.429)</td></tr><tr><td></td><td></td><td></td><td align="left" colspan="3"><italic>P</italic><sub><italic>ANOVA </italic></sub>= 0.244, <italic>P</italic><sub><italic>dom </italic></sub>= 0.214, <italic>P</italic><sub><italic>rec </italic></sub>= 0.144</td></tr><tr><td align="center">Male</td><td align="center">Total cholesterol</td><td align="center">0.31</td><td align="center">99(4.79 &#x000b1; 0.852)</td><td align="center">98(4.77 &#x000b1; 0.779)</td><td align="center">17(4.81 &#x000b1; 0.845)</td></tr><tr><td></td><td></td><td></td><td align="left" colspan="3"><italic>P</italic><sub><italic>ANOVA </italic></sub>= 0.978, <italic>P</italic><sub><italic>dom </italic></sub>= 0.916, <italic>P</italic><sub><italic>rec </italic></sub>= 0.883</td></tr><tr><td></td><td align="center">HDL cholesterol</td><td align="center">0.31</td><td align="center">99(0.884 &#x000b1; 0.0559)</td><td align="center">98(0.876 &#x000b1; 0.0185)</td><td align="center">17(0.892 &#x000b1; 0.102)</td></tr><tr><td></td><td></td><td></td><td align="left" colspan="3"><italic>P</italic><sub><italic>ANOVA </italic></sub>= 0.336, <italic>P</italic><sub><italic>dom </italic></sub>= 0.389, <italic>P</italic><sub><italic>rec </italic></sub>= 0.359</td></tr><tr><td></td><td align="center">Triglyceride</td><td align="center">0.31</td><td align="center">99(1.52 &#x000b1; 1.16)</td><td align="center">98(1.77 &#x000b1; 1.13)</td><td align="center">17(1.57 &#x000b1; 0.895)</td></tr><tr><td></td><td></td><td></td><td align="left" colspan="3"><italic>P</italic><sub><italic>ANOVA </italic></sub>= 0.300, <italic>P</italic><sub><italic>dom </italic></sub>= 0.157, <italic>P</italic><sub><italic>rec </italic></sub>= 0.817</td></tr></tbody></table><table-wrap-foot><p>The <italic>P </italic>values for the levels of cholesterol and triglyceride in subjects with minor alleles were assessed by an ANOVA for a difference among three genotypes or by a T-test for the dominant and recessive models. The significant threshold was 0.0015 for the Kirin population (11 phenotypes and 3 different models) and 0.0033 for the Yeungnam and Multicenter populations (5 phenotypes and 3 different models).</p></table-wrap-foot></table-wrap></sec></sec><sec><title>Discussion</title><p><italic>INSIG2</italic>, showing involvement with cholesterol metabolism in studies using the cell line and mice, has been identified as an obesity-susceptible gene in a recent whole-genome association study [<xref ref-type="bibr" rid="B1">1</xref>]. However, a number of contrasting reports exist regarding the genetic effect of the gene polymorphism (rs7566605) on obesity. The association with BMI also could not be replicated in the present research with Korean populations. The proposed relationship shown in mice between <italic>INSIG2 </italic>and cholesterol metabolism has not been verified in human studies of white [<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref>], African [<xref ref-type="bibr" rid="B12">12</xref>], Chinese [<xref ref-type="bibr" rid="B15">15</xref>], Japanese [<xref ref-type="bibr" rid="B4">4</xref>], and Uyghur [<xref ref-type="bibr" rid="B6">6</xref>] populations. Our results demonstrated that the C allele of <italic>INSIG2 </italic>rs7566605 did not significantly affect the cholesterol levels.</p><p>However, a possible relationship was found between the <italic>INSIG2 </italic>and the plasma level of total cholesterol in females (Table <xref ref-type="table" rid="T4">4</xref>). From a high-density SNP analysis in mice, <italic>Insig2 </italic>was identified as a susceptible gene in the control of plasma cholesterol levels [<xref ref-type="bibr" rid="B19">19</xref>]. <italic>Insig2 </italic>has been strongly associated with cholesterol biosynthetic genes that can be activated by <italic>Srebp-2 </italic>through construction of a transcriptional network in the female liver. This implies that the carriage of the rs7566605 C allele might weaken the blocking of SREBP activation, leading to elevated total cholesterol levels. However, a relationship between rs7566605 and the cholesterol level could not be established in the present work because there were no significant associations in the meta-analysis and the mean level of the total cholesterol was higher for heterozygotes than those of the major and minor homozygotes in the Kirin population. Therefore, it is necessary to perform an association analysis with other large populations and/or to do research on the subjects who are restricted to having a cholesterol-rich diet during a definite period in order to elucidate the relationship and conclude whether INSIG2 is related with cholesterol metabolism in humans.</p><p>Whether INSIG2 plays a role in obesity development in Korean subjects remains unclear, as a relationship between rs7566605 and BMI was not found. However, an association with obesity has been reported in many studies with white, Asian, and African populations [<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B26">26</xref>]. According to the results of Cervino et al. [<xref ref-type="bibr" rid="B19">19</xref>], <italic>INSIG2 </italic>might be related to an increase in fat mass, as <italic>Insig2 </italic>was identified upstream of several obesity-related genes in the transcriptional network. This can be supported by a study with double-knockout mice in relation to both <italic>Insig1 </italic>and <italic>Insig2</italic>, where mice given a cholesterol-rich diet gained more weight compared to a control group. From a recent study, a new polymorphism, <italic>INSIG2 </italic>-102G/A, in high linkage disequilibrium with rs7566605 (D' = 0.96 and r<sup>2 </sup>= 0.04) was found to be related to an increase in BMI and to adipogenesis through SREBP1 activation. However, no connection was found with triglyceride, cholesterol, or glucose [<xref ref-type="bibr" rid="B20">20</xref>]. The -102G/A polymorphism has been proposed as the functional polymorphism of <italic>INSIG2</italic>, as it appears to influence the level of <italic>INSIG2 </italic>expression directly though the weaker binding of nuclear factors on the -102A DNA fragment. Therefore, the genetic effects of the <italic>INSIG2 </italic>gene on fat mass accumulation can be clarified by further studies with the new putative functional variant, and the effects may be strengthened by the habitual ingestion of cholesterol-rich food.</p></sec><sec><title>Conclusion</title><p>The present study indicates there is no significant relationship between the <italic>INSIG2 </italic>gene and cholesterol levels, although the results indicate that the <italic>INSIG2 </italic>gene tended to affect the total cholesterol level that was obtained in this study. From human epidemiological studies conducted to date, the influence of <italic>INSIG2 </italic>on body fat accumulation and cholesterol metabolism is unclear. Therefore, it is necessary to determine the roles of <italic>INSIG2 </italic>in the creation of body fat and in cholesterol metabolism, and to elucidate the interplay among INSIG1 (another INSIG protein), INSIG2, and the SREBP pathway on the two metabolisms.</p></sec><sec><title>Abbreviations</title><p>AFA: abdominal fat area; ANOVA: analysis of variance; BMI: body mass index; 95% CI: confidence interval at 95%; HDL cholesterol: high-density lipoprotein cholesterol; INSIG1: insulin-induced gene 1; INSIG2: insulin-induced gene 2; MAF: minor allele frequency; PCR: polymerase chain reaction; SCAP: SREBP cleavage-activating protein; SD: standard deviation; SNP: single nucleotide polymorphism; SREBP: sterol regulatory element-binding protein; WHR: waist-to-hip ratio.</p></sec><sec><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec><title>Authors' contributions</title><p>CS designed the study, interpreted the data, and wrote the manuscript. IK performed the statistical analyses and interpretation. SMC recruited subjects and managed the clinical data. BLP assisted with study design, and directed the genotyping analyses. KSK recruited subjects and performed clinical measurements. JRK recruited subjects and performed clinical measurements. HDS participated in the study design, and involved in drafting the manuscript. JYK supervised the study by overseeing the recruitment of subjects and involved in drafting the manuscript. All authors read and approved the final manuscript.</p></sec><sec><title>Pre-publication history</title><p>The pre-publication history for this paper can be accessed here:</p><p><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2350/10/96/prepub"/></p></sec></body><back><ack><sec><title>Acknowledgements</title><p>This research was supported by a Korea Science and Engineering Foundation (KOSEF) grant funded by the Korea government (MEST) (Grant No. M10643020004-08N4302-00400).</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Herbert</surname><given-names>A</given-names></name><name><surname>Gerry</surname><given-names>NP</given-names></name><name><surname>McQueen</surname><given-names>MB</given-names></name><name><surname>Heid</surname><given-names>IM</given-names></name><name><surname>Pfeufer</surname><given-names>A</given-names></name><name><surname>Illig</surname><given-names>T</given-names></name><name><surname>Wichmann</surname><given-names>HE</given-names></name><name><surname>Meitinger</surname><given-names>T</given-names></name><name><surname>Hunter</surname><given-names>D</given-names></name><name><surname>Hu</surname><given-names>FB</given-names></name><etal></etal></person-group><article-title>A common genetic variant is associated with adult and childhood obesity</article-title><source>Science</source><year>2006</year><volume>312</volume><fpage>279</fpage><lpage>283</lpage><pub-id pub-id-type="pmid">16614226</pub-id><pub-id pub-id-type="doi">10.1126/science.1124779</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lyon</surname><given-names>HN</given-names></name><name><surname>Emilsson</surname><given-names>V</given-names></name><name><surname>Hinney</surname><given-names>A</given-names></name><name><surname>Heid</surname><given-names>IM</given-names></name><name><surname>Lasky-Su</surname><given-names>J</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Thorleifsson</surname><given-names>G</given-names></name><name><surname>Gunnarsdottir</surname><given-names>S</given-names></name><name><surname>Walters</surname><given-names>GB</given-names></name><name><surname>Thorsteinsdottir</surname><given-names>U</given-names></name><etal></etal></person-group><article-title>The association of a SNP upstream of INSIG2 with body mass index is reproduced in several but not all cohorts</article-title><source>PLoS Genet</source><year>2007</year><volume>3</volume><fpage>e61</fpage><pub-id pub-id-type="pmid">17465681</pub-id><pub-id pub-id-type="doi">10.1371/journal.pgen.0030061</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rosskopf</surname><given-names>D</given-names></name><name><surname>Bornhorst</surname><given-names>A</given-names></name><name><surname>Rimmbach</surname><given-names>C</given-names></name><name><surname>Schwahn</surname><given-names>C</given-names></name><name><surname>Kayser</surname><given-names>A</given-names></name><name><surname>Kruger</surname><given-names>A</given-names></name><name><surname>Tessmann</surname><given-names>G</given-names></name><name><surname>Geissler</surname><given-names>I</given-names></name><name><surname>Kroemer</surname><given-names>HK</given-names></name><name><surname>Volzke</surname><given-names>H</given-names></name></person-group><article-title>Comment on "A common genetic variant is associated with adult and childhood obesity"</article-title><source>Science</source><year>2007</year><volume>315</volume><fpage>187</fpage><comment>author reply 187</comment><pub-id pub-id-type="pmid">17218510</pub-id><pub-id pub-id-type="doi">10.1126/science.1130571</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hotta</surname><given-names>K</given-names></name><name><surname>Nakamura</surname><given-names>M</given-names></name><name><surname>Nakata</surname><given-names>Y</given-names></name><name><surname>Matsuo</surname><given-names>T</given-names></name><name><surname>Kamohara</surname><given-names>S</given-names></name><name><surname>Kotani</surname><given-names>K</given-names></name><name><surname>Komatsu</surname><given-names>R</given-names></name><name><surname>Itoh</surname><given-names>N</given-names></name><name><surname>Mineo</surname><given-names>I</given-names></name><name><surname>Wada</surname><given-names>J</given-names></name><etal></etal></person-group><article-title>INSIG2 gene rs7566605 polymorphism is associated with severe obesity in Japanese</article-title><source>J Hum Genet</source><year>2008</year><volume>53</volume><fpage>857</fpage><lpage>862</lpage><pub-id pub-id-type="pmid">18615239</pub-id><pub-id pub-id-type="doi">10.1007/s10038-008-0317-8</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Yu</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Lin</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name></person-group><article-title>Potential association of INSIG2 rs7566605 polymorphism with body weight in a Chinese subpopulation</article-title><source>Eur J Hum Genet</source><year>2008</year><volume>16</volume><fpage>759</fpage><lpage>761</lpage><pub-id pub-id-type="pmid">18270535</pub-id><pub-id pub-id-type="doi">10.1038/ejhg.2008.8</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Lin</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Lu</surname><given-names>M</given-names></name><name><surname>Lin</surname><given-names>RY</given-names></name><name><surname>Wang</surname><given-names>SZ</given-names></name><name><surname>Wen</surname><given-names>H</given-names></name><name><surname>Jin</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>XF</given-names></name></person-group><article-title>A common polymorphism is associated with body mass index in Uyghur population</article-title><source>Diabetes Res Clin Pract</source><year>2008</year><volume>81</volume><fpage>e11</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">18514965</pub-id><pub-id pub-id-type="doi">10.1016/j.diabres.2008.03.022</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Andreasen</surname><given-names>CH</given-names></name><name><surname>Mogensen</surname><given-names>MS</given-names></name><name><surname>Borch-Johnsen</surname><given-names>K</given-names></name><name><surname>Sandbaek</surname><given-names>A</given-names></name><name><surname>Lauritzen</surname><given-names>T</given-names></name><name><surname>Sorensen</surname><given-names>TI</given-names></name><name><surname>Hansen</surname><given-names>L</given-names></name><name><surname>Almind</surname><given-names>K</given-names></name><name><surname>Jorgensen</surname><given-names>T</given-names></name><name><surname>Pedersen</surname><given-names>O</given-names></name><etal></etal></person-group><article-title>Non-replication of genome-wide based associations between common variants in INSIG2 and PFKP and obesity in studies of 18,014 Danes</article-title><source>PLoS ONE</source><year>2008</year><volume>3</volume><fpage>e2872</fpage><pub-id pub-id-type="pmid">18682847</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0002872</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boes</surname><given-names>E</given-names></name><name><surname>Kollerits</surname><given-names>B</given-names></name><name><surname>Heid</surname><given-names>IM</given-names></name><name><surname>Hunt</surname><given-names>SC</given-names></name><name><surname>Pichler</surname><given-names>M</given-names></name><name><surname>Paulweber</surname><given-names>B</given-names></name><name><surname>Coassin</surname><given-names>S</given-names></name><name><surname>Adams</surname><given-names>TD</given-names></name><name><surname>Hopkins</surname><given-names>PN</given-names></name><name><surname>Lingenhel</surname><given-names>A</given-names></name><etal></etal></person-group><article-title>INSIG2 polymorphism is neither associated with BMI nor with phenotypes of lipoprotein metabolism</article-title><source>Obesity (Silver Spring)</source><year>2008</year><volume>16</volume><fpage>827</fpage><lpage>833</lpage><pub-id pub-id-type="pmid">18239574</pub-id><pub-id pub-id-type="doi">10.1038/oby.2007.132</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dina</surname><given-names>C</given-names></name><name><surname>Meyre</surname><given-names>D</given-names></name><name><surname>Samson</surname><given-names>C</given-names></name><name><surname>Tichet</surname><given-names>J</given-names></name><name><surname>Marre</surname><given-names>M</given-names></name><name><surname>Jouret</surname><given-names>B</given-names></name><name><surname>Charles</surname><given-names>MA</given-names></name><name><surname>Balkau</surname><given-names>B</given-names></name><name><surname>Froguel</surname><given-names>P</given-names></name></person-group><article-title>Comment on "A common genetic variant is associated with adult and childhood obesity"</article-title><source>Science</source><year>2007</year><volume>315</volume><fpage>187</fpage><comment>author reply 187</comment><pub-id pub-id-type="pmid">17218508</pub-id><pub-id pub-id-type="doi">10.1126/science.1129402</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>DH</given-names></name><name><surname>Rahman</surname><given-names>T</given-names></name><name><surname>Avery</surname><given-names>PJ</given-names></name><name><surname>Keavney</surname><given-names>B</given-names></name></person-group><article-title>INSIG-2 promoter polymorphism and obesity related phenotypes: association study in 1428 members of 248 families</article-title><source>BMC Med Genet</source><year>2006</year><volume>7</volume><fpage>83</fpage><pub-id pub-id-type="pmid">17137505</pub-id><pub-id pub-id-type="doi">10.1186/1471-2350-7-83</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Loos</surname><given-names>RJ</given-names></name><name><surname>Barroso</surname><given-names>I</given-names></name><name><surname>O'Rahilly</surname><given-names>S</given-names></name><name><surname>Wareham</surname><given-names>NJ</given-names></name></person-group><article-title>Comment on "A common genetic variant is associated with adult and childhood obesity"</article-title><source>Science</source><year>2007</year><volume>315</volume><fpage>187</fpage><comment>author reply 187</comment><pub-id pub-id-type="pmid">17218509</pub-id><pub-id pub-id-type="doi">10.1126/science.1130012</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>AJ</given-names></name><name><surname>Cooper</surname><given-names>JA</given-names></name><name><surname>Li</surname><given-names>LK</given-names></name><name><surname>Humphries</surname><given-names>SE</given-names></name></person-group><article-title>INSIG2 gene polymorphism is not associated with obesity in Caucasian, Afro-Caribbean and Indian subjects</article-title><source>Int J Obes (Lond)</source><year>2007</year><volume>31</volume><fpage>1753</fpage><lpage>1755</lpage><pub-id pub-id-type="pmid">17471297</pub-id><pub-id pub-id-type="doi">10.1038/sj.ijo.0803645</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vimaleswaran</surname><given-names>KS</given-names></name><name><surname>Franks</surname><given-names>PW</given-names></name><name><surname>Brage</surname><given-names>S</given-names></name><name><surname>Sardinha</surname><given-names>LB</given-names></name><name><surname>Andersen</surname><given-names>LB</given-names></name><name><surname>Wareham</surname><given-names>NJ</given-names></name><name><surname>Ekelund</surname><given-names>U</given-names></name><name><surname>Loos</surname><given-names>RJ</given-names></name></person-group><article-title>Absence of Association Between the INSIG2 Gene Polymorphism (rs7566605) and Obesity in the European Youth Heart Study (EYHS)</article-title><source>Obesity (Silver Spring)</source><year>2009</year><volume>17</volume><fpage>1453</fpage><lpage>1457</lpage><pub-id pub-id-type="pmid">19197262</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wiedmann</surname><given-names>S</given-names></name><name><surname>Neureuther</surname><given-names>K</given-names></name><name><surname>Stark</surname><given-names>K</given-names></name><name><surname>Reinhard</surname><given-names>W</given-names></name><name><surname>Kallmunzer</surname><given-names>B</given-names></name><name><surname>Baessler</surname><given-names>A</given-names></name><name><surname>Fischer</surname><given-names>M</given-names></name><name><surname>Linsel-Nitschke</surname><given-names>P</given-names></name><name><surname>Erdmann</surname><given-names>J</given-names></name><name><surname>Schunkert</surname><given-names>H</given-names></name><etal></etal></person-group><article-title>Lack of Association Between a Common Polymorphism Near the INSIG2 Gene and BMI, Myocardial Infarction, and Cardiovascular Risk Factors</article-title><source>Obesity (Silver Spring)</source><year>2009</year><volume>17</volume><fpage>1390</fpage><lpage>1395</lpage><pub-id pub-id-type="pmid">19197259</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>Y</given-names></name><name><surname>Dong</surname><given-names>H</given-names></name><name><surname>Xiang</surname><given-names>Q</given-names></name><name><surname>Hong</surname><given-names>X</given-names></name><name><surname>Wilker</surname><given-names>E</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name></person-group><article-title>Lack of association between rs7566605 and obesity in a Chinese population</article-title><source>Hum Genet</source><year>2007</year><volume>120</volume><fpage>743</fpage><lpage>745</lpage><pub-id pub-id-type="pmid">17024366</pub-id><pub-id pub-id-type="doi">10.1007/s00439-006-0258-2</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oki</surname><given-names>K</given-names></name><name><surname>Yamane</surname><given-names>K</given-names></name><name><surname>Kamei</surname><given-names>N</given-names></name><name><surname>Asao</surname><given-names>T</given-names></name><name><surname>Awaya</surname><given-names>T</given-names></name><name><surname>Kohno</surname><given-names>N</given-names></name></person-group><article-title>The single nucleotide polymorphism upstream of insulin-induced gene 2 (INSIG2) is associated with the prevalence of hypercholesterolaemia, but not with obesity, in Japanese American women</article-title><source>Br J Nutr</source><year>2008</year><volume>101</volume><fpage>322</fpage><lpage>327</lpage><pub-id pub-id-type="pmid">18570692</pub-id><pub-id pub-id-type="doi">10.1017/S0007114508006557</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tabara</surname><given-names>Y</given-names></name><name><surname>Kawamoto</surname><given-names>R</given-names></name><name><surname>Osawa</surname><given-names>H</given-names></name><name><surname>Nakura</surname><given-names>J</given-names></name><name><surname>Makino</surname><given-names>H</given-names></name><name><surname>Miki</surname><given-names>T</given-names></name><name><surname>Kohara</surname><given-names>K</given-names></name></person-group><article-title>No association between INSIG2 Gene rs7566605 polymorphism and being overweight in Japanese population</article-title><source>Obesity (Silver Spring)</source><year>2008</year><volume>16</volume><fpage>211</fpage><lpage>215</lpage><pub-id pub-id-type="pmid">18223638</pub-id><pub-id pub-id-type="doi">10.1038/oby.2007.25</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yabe</surname><given-names>D</given-names></name><name><surname>Brown</surname><given-names>MS</given-names></name><name><surname>Goldstein</surname><given-names>JL</given-names></name></person-group><article-title>Insig-2, a second endoplasmic reticulum protein that binds SCAP and blocks export of sterol regulatory element-binding proteins</article-title><source>Proc Natl Acad Sci USA</source><year>2002</year><volume>99</volume><fpage>12753</fpage><lpage>12758</lpage><pub-id pub-id-type="pmid">12242332</pub-id><pub-id pub-id-type="doi">10.1073/pnas.162488899</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cervino</surname><given-names>AC</given-names></name><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Edwards</surname><given-names>S</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Laurie</surname><given-names>C</given-names></name><name><surname>Tokiwa</surname><given-names>G</given-names></name><name><surname>Lum</surname><given-names>PY</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Castellini</surname><given-names>LW</given-names></name><name><surname>Lusis</surname><given-names>AJ</given-names></name><etal></etal></person-group><article-title>Integrating QTL and high-density SNP analyses in mice to identify Insig2 as a susceptibility gene for plasma cholesterol levels</article-title><source>Genomics</source><year>2005</year><volume>86</volume><fpage>505</fpage><lpage>517</lpage><pub-id pub-id-type="pmid">16126366</pub-id><pub-id pub-id-type="doi">10.1016/j.ygeno.2005.07.010</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krapivner</surname><given-names>S</given-names></name><name><surname>Popov</surname><given-names>S</given-names></name><name><surname>Chernogubova</surname><given-names>E</given-names></name><name><surname>Hellenius</surname><given-names>ML</given-names></name><name><surname>Fisher</surname><given-names>RM</given-names></name><name><surname>Hamsten</surname><given-names>A</given-names></name><name><surname>van't Hooft</surname><given-names>FM</given-names></name></person-group><article-title>Insulin-induced gene 2 involvement in human adipocyte metabolism and body weight regulation</article-title><source>J Clin Endocrinol Metab</source><year>2008</year><volume>93</volume><fpage>1995</fpage><lpage>2001</lpage><pub-id pub-id-type="pmid">18319320</pub-id><pub-id pub-id-type="doi">10.1210/jc.2007-1850</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>JR</given-names></name><name><surname>Jung</surname><given-names>HS</given-names></name><name><surname>Bae</surname><given-names>SW</given-names></name><name><surname>Kim</surname><given-names>JH</given-names></name><name><surname>Park</surname><given-names>BL</given-names></name><name><surname>Choi</surname><given-names>YH</given-names></name><name><surname>Cho</surname><given-names>HY</given-names></name><name><surname>Cheong</surname><given-names>HS</given-names></name><name><surname>Shin</surname><given-names>HD</given-names></name></person-group><article-title>Polymorphisms in FOXO gene family and association analysis with BMI</article-title><source>Obesity (Silver Spring)</source><year>2006</year><volume>14</volume><fpage>188</fpage><lpage>193</lpage><pub-id pub-id-type="pmid">16571842</pub-id><pub-id pub-id-type="doi">10.1038/oby.2006.24</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cha</surname><given-names>SW</given-names></name><name><surname>Choi</surname><given-names>SM</given-names></name><name><surname>Kim</surname><given-names>KS</given-names></name><name><surname>Park</surname><given-names>BL</given-names></name><name><surname>Kim</surname><given-names>JR</given-names></name><name><surname>Kim</surname><given-names>JY</given-names></name><name><surname>Shin</surname><given-names>HD</given-names></name></person-group><article-title>Replication of genetic effects of FTO polymorphisms on BMI in a Korean population</article-title><source>Obesity (Silver Spring)</source><year>2008</year><volume>16</volume><fpage>2187</fpage><lpage>2189</lpage><pub-id pub-id-type="pmid">18551112</pub-id><pub-id pub-id-type="doi">10.1038/oby.2008.314</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matsuzawa</surname><given-names>Y</given-names></name><name><surname>Nakamura</surname><given-names>T</given-names></name><name><surname>Shimomura</surname><given-names>I</given-names></name><name><surname>Kotani</surname><given-names>K</given-names></name></person-group><article-title>Visceral fat accumulation and cardiovascular disease</article-title><source>Obes Res</source><year>1995</year><volume>3</volume><fpage>645S</fpage><lpage>647S</lpage><pub-id pub-id-type="pmid">8653544</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>HD</given-names></name><name><surname>Kim</surname><given-names>KS</given-names></name><name><surname>Cha</surname><given-names>MH</given-names></name><name><surname>Yoon</surname><given-names>Y</given-names></name></person-group><article-title>The effects of UCP-1 polymorphisms on obesity phenotypes among Korean female subjects</article-title><source>Biochem Biophys Res Commun</source><year>2005</year><volume>335</volume><fpage>624</fpage><lpage>630</lpage><pub-id pub-id-type="pmid">16084837</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Livak</surname><given-names>KJ</given-names></name></person-group><article-title>Allelic discrimination using fluorogenic probes and the 5' nuclease assay</article-title><source>Genet Anal</source><year>1999</year><volume>14</volume><fpage>143</fpage><lpage>149</lpage><pub-id pub-id-type="pmid">10084106</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Orkunoglu-Suer</surname><given-names>FE</given-names></name><name><surname>Gordish-Dressman</surname><given-names>H</given-names></name><name><surname>Clarkson</surname><given-names>PM</given-names></name><name><surname>Thompson</surname><given-names>PD</given-names></name><name><surname>Angelopoulos</surname><given-names>TJ</given-names></name><name><surname>Gordon</surname><given-names>PM</given-names></name><name><surname>Moyna</surname><given-names>NM</given-names></name><name><surname>Pescatello</surname><given-names>LS</given-names></name><name><surname>Visich</surname><given-names>PS</given-names></name><name><surname>Zoeller</surname><given-names>RF</given-names></name><etal></etal></person-group><article-title>INSIG2 gene polymorphism is associated with increased subcutaneous fat in women and poor response to resistance training in men</article-title><source>BMC Med Genet</source><year>2008</year><volume>9</volume><fpage>117</fpage><pub-id pub-id-type="pmid">19105843</pub-id><pub-id pub-id-type="doi">10.1186/1471-2350-9-117</pub-id></citation></ref></ref-list></back></article> 